Episodes

Reviews

Analytics

Clips

May 31, 2019
The Magic of the Serotonin Receptors
In this podcast episode, we explore with Dr. David Nutt (Imperial College London) the serotonin receptors 5-HT1A and 5-HT2A and their links to clinical psychiatry. We particularly focus on their roles in mood, anxiety, psychosis, aggression, and learning.
More info...
23 min
May 16, 2019
Generalized Anxiety Disorder: What if You Can’t Use An SSRI?
In this podcast episode, we answer the question: What if you can’t use an SSRI for GAD? With expert commentary from Dr. David Osser (Harvard Medical School), we explore different options and also highlight what not to use.
More info...
17 min
May 3, 2019
Approaching A Case of Generalized Anxiety Disorder: The Basics
In this podcast episode, we cover the treatment algorithm of generalized anxiety disorder. Dr. David Osser (Harvard Medical School) shares practical tips and anecdotes for your practice.
More info...
18 min
April 17, 2019
How Helpful are Antipsychotic Plasma Levels?
In this podcast episode, we investigate the effectiveness of using antipsychotic plasma levels in clinical practice with Dr. Jonathan Meyer (University of California San Diego).
More info...
16 min
April 8, 2019
Should You Prescribe Natural Medications? Part 2
In this podcast episode, we learn about prescribing natural medications in psychiatry with Dr. David Mischoulon (Harvard Medical School). We explore the use of melatonin, Valerian and Ginkgo biloba.
More info...
15 min
March 21, 2019
How to Prescribe Natural Medications? Part 1
In this podcast episode, we learn about prescribing natural medications in psychiatry with Dr. David Mischoulon (Harvard Medical School). We explore St. John’s wort, SAM-e, Omega 3 fatty acids and Rhodiola rosea.
More info...
15 min
March 8, 2019
How to Manage Adverse Effects of Clozapine – Part 2
In this episode, we cover practical tips on the management of fever, cardiovascular and cardiometabolic adverse effects related to clozapine use. Dr. Jonathan Meyer provides evidence-based pearls as well as clinical anecdotes.
More info...
13 min
February 21, 2019
How to Manage Adverse Effects of Clozapine – Part 1
In this episode, we cover practical tips on the management of sialorrhea, constipation, sedation, and seizures related to clozapine use. Dr. Jonathan Meyer provides evidence-based pearls as well as clinical anecdotes.
More info...
16 min
February 6, 2019
Do SSRIs Increase Bleeding Risk?
In this episode we answer the question: Do SSRIs increase the risk of bleeding? We do this with Dr. James Levenson (Virginia Commonwealth University) and we explore GIT, perioperative, CNS and postpartum bleeding with SSRIs.
More info...
13 min
January 25, 2019
Your Guide to Treating PTSD Comorbidities
In this episode, we explore the management of common PTSD comorbidities with Prof. David Osser (Harvard Medical School). We cover substance use disorder, depression, psychosis and prescribing in women of childbearing potential.
More info...
11 min
January 9, 2019
How to Treat PTSD-Related Sleep Disturbances?
In this episode, we discuss part of Dr. David Osser’s (Harvard Medical School) PTSD algorithm about treating sleep symptoms of PTSD. We cover the evidence on prazosin’s efficacy and trazodone use. The rationale behind certain drugs to avoid is also covered.
More info...
20 min
December 28, 2018
Prescribing Psychotropics in the Medically Ill
In this episode, we review principles of prescribing psychotropics in patients with liver, kidney and lung diseases with Dr. James Levenson (Virginia Commonwealth University).
More info...
10 min
December 14, 2018
Psychotropics and Gastrointestinal Conditions: Prescribe with the Gut in Mind
In this episode, we learn to prescribe with the gut in mind. Dr. James Levenson (Virginia Commonwealth University) joins us with to-the-point tips on prescribing psychotropics in patients with GI disease as well as exploring how psychotropics can affect the GIT.
More info...
16 min
November 29, 2018
Clinical Pearls in Geriatric Psychopharmacology
In this episode, we uncover clinical pearls of geriatric psychopharmacology. We are joined by Dr. Sandra Jacobson of the University of Arizona giving practical tips on prescribing for this special group of patients.
More info...
20 min
November 15, 2018
Treatment-Resistant Depression: Clinical Conundrum
In this podcast episode, we take on the challenge of treatment-resistant depression and its therapeutic options. Dr. Philip Cowen (University of Oxford) provided insights for this clinical conundrum with a simple algorithm.
More info...
26 min
October 30, 2018
How to Manage an Agitated Patient?
In this episode, we venture into the psychopharmacology of agitation, with a special focus on psychotic agitation. Dr. Michael Jibson (University of Michigan) and Dr. David Osser (Harvard Medical School) shared clinical pearls to treat this challenging situation.
More info...
17 min
October 2, 2018
When to Discontinue Antipsychotics? Reviewing the Evidence
When is the right time to discontinue an antipsychotic in the treatment of schizophrenia? We reviewed the evidence as well as consulting Dr. Ira Glick to help us answer this question.
More info...
8 min
August 27, 2018
Are Drug Interaction Warnings Influenced by Drug Company Promotion? An Interview with Dr. Jeffery Mattes
Dr. Jeffrey Mattes, psychiatrist in Princeton, New Jersey speaks about drug interaction warnings that appear during electronic prescribing and how these warnings may be influenced by drug company promotion. This interview is part of a series covering the 2018 ASCP Annual Meeting.
More info...
9 min
July 29, 2018
Psilocybin for Treatment-Resistant Depression - Dr. Robin Carhart-Harris
Dr. Robin Carhart-Harris speaks about the use of psilocybin for treatment-resistant depression.  - Psilocybin, a psychedelic, is a 5-HT2A agonist.  Stimulation of the 5-HT2A receptor promotes neural plasticity -A potential mechanism of action of psilocybin in treatment-resistant depression involves “brain resetting” - Psilocybin has a good safety profile. However, patients may experience challenging psychological experiences that may turn out to be frightening for some people
More info...
14 min
July 29, 2018
Are Psychopharm Algorithms Bad for You?
At the 2018 Annual Meeting of the American Psychiatric Association, Dr. Robert Patterson (psychiatrist at McLean Hospital Boston) spoke about the benefits of following a structured approach to psychopharmacology. In this episoder, Dr. Patterson explains why algorithms are good for patient outcomes and how they support clear decision making.
More info...
6 min
Feedback on the new Podbay?
    1x
    15
    15
    00:00:00
      00:00:00